Cargando…
The growing importance of lesion volume as a prognostic factor in patients with multiple brain metastases treated with stereotactic radiosurgery
Stereotactic Radiosurgery (SRS) is considered standard of care for patients with 1–3 brain metastases (BM). Recent observational studies have shown equivalent OS in patients with 5+ BM compared to those with 2–4, suggesting SRS alone may be appropriate in these patients. We aim to review outcomes of...
Autores principales: | Routman, David M., Bian, Shelly X., Diao, Kevin, Liu, Jonathan L., Yu, Cheng, Ye, Jason, Zada, Gabriel, Chang, Eric L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852368/ https://www.ncbi.nlm.nih.gov/pubmed/29441722 http://dx.doi.org/10.1002/cam4.1352 |
Ejemplares similares
-
Preoperative Stereotactic Radiosurgery for Brain Metastases
por: Routman, David M., et al.
Publicado: (2018) -
Efficacy of Stereotactic Radiosurgery in Patients with Multiple Metastases: Importance of Volume Rather Than Number of Lesions
por: Dahshan, Basem A, et al.
Publicado: (2017) -
Survival of melanoma patients with brain metastases treated with ipilimumab and stereotactic radiosurgery
por: Tazi, Karim, et al.
Publicado: (2015) -
Stereotactic radiosurgery and stereotactic radiotherapy for brain metastases
por: Halasz, Lia M., et al.
Publicado: (2013) -
Stereotactic Radiosurgery and Ipilimumab Versus Stereotactic Radiosurgery Alone in Melanoma Brain Metastases
por: Nguyen, Steven M, et al.
Publicado: (2017)